One of the most interesting emerging competitors in the peripheral vascular stenting space is UK-based Veryan Medical Ltd. The privately held, venture-funded company has developed a unique yet straightforward method of producing lower-extremity stents it believes will be more resistant to both fracture and restenosis – by changing the stent shape from a straight tube to a 3-D helical geometry.
Veryan Medical: Improving Stent Performance With 3-D, Helical Geometry
More from Archive
More from Medtech Insight
• By
Abbott has also added new customization options to enhance user comfort and discretion. These include a “silent mode” feature for FreeStyle Libre 3 systems, allowing users to mute glucose alarms for up to six hours – a useful option during meetings, sleep, or other moments where audio alerts may be disruptive.
• By
Cambridge-based startup Mursla Bio's liquid biopsy test EvoLiver uses extracellular vesicles to detect hepatocellular carcinoma (HCC) in high-risk cirrhotic patients. Medtech Insight sat down with with Mursla Bio CEO Pierre Arsène.
• By
Biolinq plans to use the proceeds of its new venture funding to support US FDA de novo review, automation engineering and commercialization efforts with partners, CEO Rich Yang told Medtech Insight.